Acorda Therapeutics Says European Commission Granted Marketing Authorization For Inbrija 33mg Inhalation Powder, Hard Capsules;  Marketing Authorization Approves Inbrija For Use In 28 EU Countries, As Well As Iceland, Norway And Liechtenstein